April 16 (Reuters) - The U.S. Food and Drug
Administration on Tuesday alerted health care professionals and
consumers that unsafe counterfeit versions of AbbVie's ( ABBV )
Botox were found in multiple states and given to consumers for
cosmetic purposes.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini
Ganguli)